Renzenbrink & Partner advises TeleClinic on Series A financing round

7 October 2018

The health care start-up TeleClinic has closed a Series A financing round on the basis of which the French financial investor Idinvest Partners has acquired a stake in the company.

Munich-based TeleClinic offers remote medical treatment by cooperating doctors and is the first company in Germany which has obtained the permission for exclusive remote medical treatment. The doctors of TeleClinic are allowed to diagnose and treat patients via the internet, in particular, via video consultation. As the only provider in Germany, TeleClinic GmbH may furthermore issue a fully functional e-prescription, including the necessary digital doctor’s signature.

Headquartered in Paris and active throughout Europe, Idinvest Partners is an investment company with over 6 billion euros under management specialized on the low and middle market segments. Idinvest Partners’ focus of investment is on innovative companies with high growth potential.
Renzenbrink & Partner has comprehensively advised TeleClinic GmbH on all aspects of the financing round. The firm has outstanding expertise in advising start-up companies as well as investors on venture capital transactions. The team of Renzenbrink & Partner comprised partners Dr Dennis Schlottmann and Dr Ulf Renzenbrink (both Corporate/Venture Capital) as well as associate Dr Alexander Haunschild (Corporate/Venture Capital).